Sexual dimorphism in SMAD3 pathogenic variant-harbouring individuals
- 2 January 2025
- journal article
- research article
- Published by BMJ in Journal of Medical Genetics
- Vol. 62 (3) , 199-205
Abstract
Background: Individuals harbouring SMAD3 pathogenic variants are at risk for aneurysms/dissections throughout the arterial tree. Based on prior reports of sex differences in thoracic aortic aneurysm/dissection, we investigated the sexual dimorphism for vascular events in SMAD3-variant-harbouring patients. Methods: We analysed two large pedigrees comprising 84 individuals segregating pathogenic missense variants affecting the same p.Arg287 residue in SMAD3. We excluded individualsSMAD3 patients reported in the literature between 2011 and 2023. Results: In our two pedigrees, 11/30 (37%) variant-harbouring females had no vascular involvement, whereas none of the variant-harboring males (n=23) had no vascular involvement (p=0.001). While the two groups did not differ by age, males were at higher risk of vascular complications (p=0.037), there was no age difference between sexes. Of the 19 females with vascular involvement, six (32%) had vascular involvment sparing the aortic root/ascending aorta, whereas of the 23 males with vascular invovlement, only one (4%) had vascular involvement sparing the aortic root/ascending aorta (p=0.034). In the literature, we identified 116 male and 62 female additional patients. In the combined cohort of 220 patients, we demonstrated an over-representation of males (p<0.001) and non-penetrance in females for vascular pathology involving the aortic root/ascending aorta (p=0.028). Conclusions: Non-penetrance is more common in women, and normal echocardiography in at-risk females is not as reassuring for risk of vasculopathy in other locations. The higher non-penetrance in women creates an ascertainment bias and results in an over-representation of male patients in the literature.Keywords
Funding Information
- University of Antwerp (GOA 33933, Methusalem-OEC grant “Genomed” 40709)
- Dutch Heart Foundation (2013T093)
- Fonds Wetenschappelijk Onderzoek (FWO, Belgium, G044720N)
- H2020 European Research Council (Genomia – ERC-COG-2017-771945)
- Belgian Cardiac Surgery Foundation and the Marfan Foundation (n/a)
- VASCERN (project ID: 769036)
This publication has 49 references indexed in Scilit:
- Diagnostic yield of clinical exome sequencing in adulthood in medical genetics clinicsAmerican Journal of Medical Genetics Part A, 2022
- The first reported case of Loeys‐Dietz syndrome in a patient with biallelic SMAD3 variantsAmerican Journal of Medical Genetics Part A, 2020
- Results of next-generation sequencing gene panel diagnostics including copy-number variation analysis in 810 patients suspected of heritable thoracic aortic disordersHuman Mutation, 2018
- A mutation update on the LDS-associated genesTGFB2/3andSMAD2/3Human Mutation, 2018
- Thoracic aortic aneurysm in patients with loss of function Filamin A mutations: Clinical characterization, genetics, and recommendationsAmerican Journal of Medical Genetics Part A, 2018
- Marfan Syndrome and Related Disorders: 25 Years of Gene DiscoveryHuman Mutation, 2016
- Clinically relevant variants identified in thoracic aortic aneurysm patients by research exome sequencingAmerican Journal of Medical Genetics Part A, 2016
- Clinical utility of a next generation sequencing panel assay for Marfan and Marfan‐like syndromes featuring aortopathyAmerican Journal of Medical Genetics Part A, 2015
- Thoracic Aortic Aneurysm in Infancy in Aneurysms–Osteoarthritis Syndrome Due to a Novel SMAD3 Mutation: Further Delineation of the PhenotypeAmerican Journal of Medical Genetics Part A, 2013
- GenTAC registry report: Gender differences among individuals with genetically triggered thoracic aortic aneurysm and dissectionAmerican Journal of Medical Genetics Part A, 2013